CVS HEALTH CORPORATION
CVSCVS Health Corporation is a healthcare company that operates the largest pharmacy chain in the United States, offering prescription drugs, health and wellness products, and retail clinics. Founded in 1963, it has expanded to include health insurance services through its acquisition of Aetna, aiming to integrate pharmacy, health, and wellness services for consumers.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 3, 2025 | $0.67 | 2025-10-23 | 2025-10-23 |
| August 1, 2025 | $0.67 | 2025-07-22 | 2025-07-22 |
| May 1, 2025 | $0.67 | 2025-04-22 | 2025-04-22 |
| February 3, 2025 | $0.67 | 2025-01-23 | 2025-01-23 |
| November 1, 2024 | $0.67 | 2024-10-21 | 2024-10-21 |
Dividends Summary
- CVS HEALTH CORPORATION has issued 88 dividend payments over the past 21 years
- The most recent dividend was paid 21 days ago, on November 3, 2025
- The highest dividend payed out to investors during this period was $0.67 per share
- The average dividend paid during this period was $0.32 per share.
Company News
Boston-based Solel Partners fully exited its stake in Paramount Group, selling 4.2 million shares for $25.6 million in Q3, likely due to the pending Rithm Capital acquisition and limited future upside.
The global E-pharmacy market is expected to grow from USD 96.94 billion in 2024 to USD 435.82 billion by 2034, with a 16.44% CAGR. North America currently leads the market, while Asia Pacific is anticipated to be the fastest-growing region, driven by technological innovations and digital health initiatives.
CVS Health reported strong Q3 earnings, beating analyst expectations with $102.87 billion in sales and raising its fiscal 2025 adjusted earnings guidance to $6.55-$6.65 per share.
UnitedHealth Group (UNH) faces regulatory probes, leadership changes, and lawsuits, leading to a 31% stock decline. However, the company's dominant market position, vertically integrated ecosystem, and strong financials suggest it may be too big to break, similar to Boeing's position in the aviation industry.
CVS Health has seen a substantial 24% decline in the past three months, trading below its 50-day and 200-day moving averages. The company is grappling with the industry-wide pharmacy reimbursement crisis and labor shortages, but its 2025 roadmap and strategic initiatives offer a potential pathway to recovery.
